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Abstract Active maintenance of membrane phospholipid asym-
metry is universal in normal cell membranes and its disruption
with subsequent externalization of phosphatidylserine is a
hallmark of apoptosis. Externalized phosphatidylserine appears
to serve as an important signal for targeting recognition and
elimination of apoptotic cells by macrophages, however, the
molecular mechanisms responsible for phosphatidylserine trans-
location during apoptosis remain unresolved. Studies have
focused on the function of aminophospholipid translocase and
phospholipid scramblase as mediators of this process. Here we
present evidence that unique oxidative events, represented by
selective oxidation of phosphatidylserine, occur during apoptosis
that could promote phosphatidylserine externalization. We
speculate that selective phosphatidylserine oxidation could affect
phosphatidylserine recognition by aminophospholipid translocase
and/or directly result in enzyme inhibition. The potential
interactions between the anionic phospholipid phosphatidylserine
and the redox-active cationic protein effector of apoptosis,
cytochrome c, are presented as a potential mechanism to ac-
count for selective oxidation of phosphatidylserine during apop-
tosis. Thus, cytochrome c-mediated phosphatidylserine oxidation
may represent an important component of the apoptotic
pathway. ß 2000 Federation of European Biochemical Socie-
ties. Published by Elsevier Science B.V. All rights reserved.
1. Introduction
The ‘raison d’etre’ for the plethora of di¡erent molecular
species of phospholipids in membranes is not clearly under-
stood at the molecular level. Neither are cellular functions of
individual phospholipid species well described (with perhaps
the notable exceptions of phosphoinositol-derived signaling
products and precursors of bioactive eicosanoids). Despite
that, asymmetric distribution of major phospholipid classes
across membranes has been established as a fundamental fea-
ture of all cells whose disturbance is incompatible with phys-
iological functions of membranes and with cell viability [1,2].
Although membrane lipid asymmetry has been known for
many years, the mechanisms for maintaining or regulating
the transbilayer lipid distribution are still not completely
understood. Recently, three major enzymatic pathways in-
volved in phospholipid transbilayer asymmetry have been
identi¢ed: (1) an inward-directed pump, an ATP-dependent
transporter speci¢c for aminophospholipids (phosphatidyl-
serine (PS) and phosphatidylethanolamine (PE)), known as
aminophospholipid translocase (APT) or ‘£ippase’ ; (2) a
phospholipid scramblase, which facilitates bi-directional mi-
gration of all phospholipid classes independent of the polar
headgroup across the bilayer; and (3) an outward-directed
pump referred to as ‘£oppase’ with little selectivity for the
polar headgroup of the phospholipid [3]. The actual partici-
pation of the latter in transport of phospholipids has not been
¢rmly established.
The concerted action of APT and ‘£oppase’ is believed to
account for the maintenance of lipid asymmetry in intact cells
[3]. The surveillance function of APT provides for the rapid
inward translocation of aminophospholipids, while ‘£oppase’
may facilitate the transbilayer movement of phospholipids to
replace aminophospholipids. APT inhibition by itself, how-
ever, does not lead to spontaneous redistribution of lipids
[4,5]. Conditions of cellular activation characterized by ele-
vated levels of intracellular Ca2 can cause collapse of lipid
asymmetry by activation of an ATP-independent scramblase
and subsequent bi-directional movement of all phospholipid
classes [6]. Thus, both inhibition of the APT and activation of
the scramblase are necessary for a collapse of lipid asymme-
try, manifested by exposure of PS on the cell surface [3]. The
latter phenomenon, known as PS externalization, has been
identi¢ed as one of the early and prominent features of pro-
grammed cell death or apoptosis [7,8]. PS exposure on the
outer lea£et of the plasma membrane is a surface change
common to many apoptotic cells and has several potential
biological consequences, one of which is recognition and re-
moval of the apoptotic cell by phagocytes [9]. It is still not
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clear which receptors mediate PS recognition on apoptotic
cells ; however, several candidates have been proposed. These
include the class B scavenger and thrombospondin receptor
(CD36), an oxidized LDL receptor (CD68), CD14, annexins,
L2 glycoprotein I, gas-6, and a novel protein expressed on
macrophages stimulated with digestible particles such as
L-glucan. Whether PS is the sole ligand recognized by phago-
cytes or whether it is associated with other molecules to form
a complex ligand is unknown [10].
If inhibition of APT (along with the activation of scram-
blase) is critical for aminophospholipid externalization, then
one would expect that both PS and PE should be exposed on
the outer surface of the plasma membrane in apoptotic cells.
Numerous data, however, indicate that PS, rather than PE, is
predominantly externalized on plasma membranes of apop-
totic cells. To some extent, this conclusion may be based on
the speci¢city of the assay for PS externalization. A negatively
charged PS can speci¢cally bind £uorescently labeled annexin
V, the most commonly used reagent for £ow cytometric mea-
surements of apoptosis [11,12]. In other words, the annexin V
binding assay ignores any potential contribution of PE to
aminophospholipid externalization. High-performance thin-
layer chromatography (HP-TLC) assays of aminophospholi-
pids chemically labeled on the cell surface by non-permeating
reagents, however, demonstrated that the degree of PS exter-
nalization far exceeds that of PE during apoptosis in di¡erent
cells [9,13,14]. This suggests that some, as yet unidenti¢ed,
factor(s) may be responsible for predominant translocation
of PS in plasma membranes of apoptotic cells.
2. Measurements of peroxidation in di¡erent classes of
phospholipids in live cells
Oxidative stress is a frequent trigger of apoptosis in a vari-
ety of cells and is also thought to be involved as a component
of the common pathway in execution of apoptosis [15^21].
While e¡ects of oxidative stress on apoptotic machinery,
such as caspases [22,23], have been well characterized, the
information on selective oxidation of speci¢c classes of phos-
pholipids is scarce. This is mainly due to the fact that quanti-
tative assays for oxidation of di¡erent classes of phospholipids
are not readily available. One of the major reasons for this is
a very e¡ective system of remodeling and repair of oxidatively
modi¢ed phospholipids [24] that interferes with their accurate
measurement.
In our attempts to characterize phospholipid oxidation dur-
ing oxidative stress-induced apoptosis, we metabolically la-
beled cellular phospholipids with a natural oxidation-sensitive
and highly £uorescent fatty acid, cis-parinaric acid (PnA).
This reagent has been extensively used in its free (non-esteri-
¢ed) form for structural measurements in membranes as well
as for assays of oxidative stress in simple model systems
[25,26]. We recently developed and optimized conditions
that yielded cells containing the major phospholipid classes
(phosphatidylcholine (PC), PE, PS, phosphatidylinositol
(PI), diphosphatidylglycerol and sphingomyelin) £uorescently
labeled with PnA and an extremely low intracellular concen-
tration of free PnA [27]. The level of PnA labeling of endog-
enous phospholipids (W1^3 mol%) was low enough to have
minimal e¡ects on cell viability and functions yet su⁄cient to
permit quantitative detection of oxidative stress [27]. Since
free PnA was not available for phospholipid repair resolution
of major phospholipid classes by £uorescence high-perform-
ance liquid chromatography (HPLC) can be used to quantify
their oxidative damage (as a decreased content of £uorescent
PnA residues in respective phospholipid classes). Importantly,
the PnA-based assay can identify the selectivity of phospho-
lipid oxidation based on their polar head groups and it is
obviously independent of the fatty acid composition of phos-
pholipids [27,28]. In addition, the proximity of PnA-labeled
phospholipids to the sites of radical generation will also de-
termine the degree of oxidation.
3. Non-random oxidation of di¡erent classes of phospholipids
during oxidative stress-induced apoptosis
We have found that apoptosis is associated with selective
oxidation of speci¢c phospholipid classes, most notably PS.
For example, paraquat, a known inducer of oxidative stress
via CYP450 reductase-mediated redox-cycling and subsequent
production of reactive oxygen species, caused apoptosis in
32D cells as evidenced by characteristic changes in nuclear
morphology, DNA fragmentation, and PS externalization re-
vealed by annexin V binding. When 32D cells containing
PnA-labeled phospholipids were exposed to paraquat, only
two classes of phospholipids, PS and PI, underwent signi¢cant
peroxidation during a 2 h incubation [13]. Importantly, nei-
ther apoptosis nor oxidation of PS and PI was induced by
paraquat in 32D cells overexpressing the bcl-2 gene product.
These initial experiments posed several questions: (i) whether
selective oxidation of PS is typical of apoptosis induced by
other agents, (ii) what is the major intracellular compartment
where PS is oxidatively modi¢ed during apoptosis, (iii)
whether PS oxidation is an early or late event in executive
pathways of apoptosis, (iv) whether PS oxidation is required
for PS externalization (and other apoptotic mechanisms), (v)
what may act as an endogenous catalyst for selective PS ox-
idation during apoptosis?
Fig. 1. Cumene hydroperoxide-induced oxidation of PnA-labeled PS
and PC in intact live normal human epidermal keratinocytes
(NHEK) (A) and cell-free PnA-labeled liposomes derived from
NHEK. PnA was incorporated into normal human epidermal kera-
tinocyte phospholipids as described earlier [27]. Intact living PnA-la-
beled NHEK (A) were exposed to cumene hydroperoxide (200 WM)
for 1 h at 37‡C. PnA-labeled liposomes (B) were prepared from
PnA-loaded NHEK as described earlier [38] and similarly treated
with 200 WM cumene hydroperoxide at 37‡C for 1 h. At the end of
the incubations, total lipids were extracted by the Folch procedure
and resolved by HPLC [27]. PS, phosphatidylserine; PC, phospha-
tidylcholine. Data represent means þ S.E.M., n = 3, *P6 0.02.
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4. Oxidation of PS is selective and precedes its externalization
in cells during apoptosis
Our initial experiments with paraquat-treated 32D cells
clearly showed that PS oxidation preceded PS externalization
as measured by annexin V binding and DNA fragmentation
[13]. Similarly, in keratinocytes exposed to cumene hydroper-
oxide, selective PS oxidation occurred prior to its detection on
the cell surface by either non-permeant amino-reagents or
annexin V and in the absence of DNA laddering [29]. Fig. 1
compares the oxidation of PnA-labeled PS and PC in intact
cells (Fig. 1A) and in keratinocyte-derived liposomes (Fig. 1B)
treated with cumene hydroperoxide. Note the preferential ox-
idation of PS is observed only in intact living cells and not in
the cell-free liposome preparation. In several other cell types
such as human leukemia HL-60 cells [18], pheochromocytoma
PC12 cells [30], rat cardiomyocytes [31], selective oxidation of
PS preceded or coincided with the appearance of very early
biomarkers of the apoptotic execution pathway, caspase 3
activation and PS externalization. A summary of these and
other studies is presented in Table 1.
The fundamental association of PS oxidation with apopto-
sis was strengthened by experiments in which we used a vita-
min E homologue, 2,2,5,7,8-pentamethyl-6-hydroxy-chromane
(PMC). Here we employed the lipophilic azo-initiator of rad-
icals, 2,2P-azobis(2,4-dimethylisovaleronitrile) (AMVN), to
generate membrane-con¢ned oxidative stress and induce
apoptosis in HL-60 cells [18]. As an e¡ective radical scav-
enger, PMC was able to completely protect all phospholipids
against oxidation with the remarkable exception of PS. Fur-
thermore, PMC failed to protect HL-60 cells against apoptosis
following AMVN (Table 1). An exclusive resistance of PS to
antioxidant protection by PMC implies a unique molecular
mechanism responsible for its oxidation during apoptosis.
5. Oxidation of PS is predominantly con¢ned to plasma
membrane during oxidative stress-induced apoptosis
The temporal sequence of PS oxidation and externalization
is compatible with a casual link between these two events. If
so, PS oxidation should occur within the plasma membrane
where PS translocation events during apoptosis are known to
occur. We performed subcellular fractionation experiments in
PnA-labeled cells challenged with tert-butylhydroperoxide (t-
BuOOH). We recently documented that t-BuOOH induced
apoptosis and prominent PS oxidation in whole cell lipid ex-
tracts. Most importantly, we found that plasma membrane PS
was the largest source of oxidized PS compared to other or-
ganelles such as mitochondria, microsomes, nuclei and lyso-
somes [32]. In these cells, we also established that apoptosis
resulted in a selective externalization of PS as compared to
PE. Thus, the time course and the intracellular location of PS
oxidation support our hypothesis regarding the mechanistic
link between PS oxidation and subsequent externalization.
6. The hypothetical role of PS oxidation in its externalization
There are several potential pathways through which PS ox-
idation may mediate its externalization. As has been pointed
out, maintenance of PS asymmetry is mainly due to the ac-
tivity of APT. Inhibition of APT and activation of phospho-
lipid scramblase are required for apoptotic PS externalization
(see above). Therefore, it is of interest to explore the relation-
ships between PS oxidation and externalization and these en-
zymatic activities. APT has been reported to be sensitive to
oxidative stress [4,41,42]. In particular, oxidation of APT cys-
teines is a target for reactive oxygen species resulting in ameli-
oration of the enzyme activity. While scramblase is not acti-
vated directly by oxidants, in£ux and elevations of cytosolic
Ca2 (that could indirectly follow oxidant challenge [43,44])
are responsible for enzyme activation during apoptosis [45^
47]. The failure of APT to internalize PS may be caused by
either direct enzyme inhibition or the enzyme’s inability to
recognize oxidized PS. In the latter case, oxidized PS has to
be located in the outer lea£et of the plasma membrane. It is
noteworthy that oxidized phospholipids undergo spontaneous
‘£ip^£op’ more readily than their non-oxidized counterparts
[48]. Thus, the requirement of having oxidized PS on the cell
surface does not seem to be unrealistic. In our experiments,
however, direct inhibition of APT, as measured by 7-nitro-
Table 1
Comparison of PS oxidation, PS externalization and apoptosis in various cells exposed to oxidants
Cell line Stimuli Apoptosis PS externalization PS oxidation References
HL-60 AMVN + + + [18]
HL-60 AMVN+PMC + + + [18]
HL-60 AMVN+NO* + + 3 [14]
HL-60 t-BuOOH + + + [32]
HL-60 H2O2 + N.D. + [33]
HL-60 Cu-NTA+NO + + + Liu et al. (unpublished)
HL-60 Cu-NTA + + + [34], Kawai et al. (unpublished)
32D Paraquat + + + [13]
32D/bcl-2 Paraquat 3 3 3 [13]
PC12 Neocarzinostatin + + + [30]
PC12/bcl-2 Neocarzinostatin 3 3 3 [30]
PC12 AMVN + N.D. + [35]
PC12/bcl-2 AMVN 3 N.D. + [35]
PC12 Glutamate 3 N.D. 3 [36]
MCF-7 AMVN + N.D. + [37]
NHEK Phenol 3 N.D. 3 [38]
NHEK Hydroperoxide + + + [29]
RCm Hydroperoxide + N.D. + [31,39,40]
HL-60 = human leukemia cells, 32D = mouse hematopoietic progenitor cells, PC12 = rat pheochromocytoma cells, NHEK = normal human epi-
dermal keratinocytes, RCm = rat cardiomyocytes. N.D. signi¢es not done. Asterisk denotes that APT activity was also inhibited by both
AMVN and NO.
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2,1,3-benzoxadiazol-4-yl-PS internalization, occurred at the
same time as PS oxidation [14]. This implies that enzyme in-
hibition itself can play a role in PS externalization. The activ-
ity of the enzyme towards oxidized PS is not known and
further studies are necessary to determine the relative a⁄nity
of APT for oxidized and non-oxidized PS, as well as the
nature of the reactive species responsible for enzyme modi¢-
cation.
It should also be mentioned that PS oxidation may be suf-
¢cient but not necessary for APT inhibition and PS external-
ization during apoptosis. Indeed, we have observed that
AMVN-induced apoptosis and PS externalization in HL-60
cells occurred even after exposure to nitric oxide, which com-
pletely blocked oxidation of all membrane phospholipids, in-
cluding PS [14]. APT cysteines, however, are potential targets
for S-nitrosylation and enzyme inhibition by NO [49,50]. In
fact, we observed a decreased content of SH-groups in the
molecular weight region corresponding to APT (115 kDa)
on SDS^PAGE gels of HL-60 proteins stained by a £uores-
cent maleimide thiol reagent [14]. It should also be noted that
direct caspase-driven inactivation of APT is not likely. Using
di¡erent inhibitors of mitochondrial electron transport,
Zhuang et al. could dissociate PS externalization from caspase
activation in THP-1 cells [51]. Similarly, Fadeel et al. showed
that oxidants generated via NADPH oxidase were essential
for PS exposure during neutrophil apoptosis despite their po-
tential to inhibit caspase activity [52]. Recent studies demon-
strated that overexpression of scramblase in Raji cells, which
exhibit low constitutive expression of this enzyme, by retro-
viral transduction of phospholipid scramblase or treatment of
the cells with interferon-K, failed to confer the capacity to
expose PS in response to apoptotic stimuli [53]. However,
PS exposure in cells overexpressing scramblase could be re-
constituted only in the presence of thiol reactive agents, such
as N-ethylmaleimide, disul¢ram and diamide [53]. Thus, oxi-
dative and/or nitrosative modi¢cation of APT is likely to be
critical for PS externalization and subsequent recognition of
apoptotic cells by phagocytes. This poses the question as to
what potential molecular mechanisms are responsible for PS
oxidation/externalization.
7. Cytosolic cytochrome c as a catalyst for plasma membrane
PS peroxidation during apoptosis
It is generally accepted that release of cytochrome c from
mitochondria is one of the very early events in the develop-
ment of an apoptotic program that is a prerequisite for sub-
sequent engagement of caspase cascades and PS externaliza-
tion [54^56] (although some workers reported that PS
exposure during apoptosis preceded release of cytochrome c
and decrease in mitochondrial transmembrane potential [57]).
Using green £uorescent protein (GFP)-tagged cytochrome c,
Goldstein et al. [58] found that the release of cytochrome c-
GFP always preceded exposure of PS and the loss of plasma
membrane integrity, characteristics of apoptotic cells. More-
over, p53 activates the apoptotic machinery through induction
of the release of cytochrome c from the mitochondrial inter-
membrane space [58].
The role of cytochrome c in the initiation of caspase cas-
cades is well established and is presumed to be independent of
its redox activity [54^56,59,60]. In fact, cytochrome c contain-
ing Zn or Cu in place of Fe is su⁄cient for interactions within
procaspase protein complex and subsequent caspase activa-
tion [61]. However, the redox repercusions of cytochrome c
release from mitochondria into cytosol cannot be ignored.
Recently, Cai and Jones [21] demonstrated that departure of
cytochrome c from electron transport chains in mitochondria
is accompanied by a dramatic increase in production of reac-
tive oxygen species. This is in keeping with the antioxidant
role for cytochrome c during electron transport demonstrated
by Skulachev [62,63]. It is well known, however, that antiox-
idants may readily be subverted to prooxidants when highly
orchestrated redox conditions in the environment are dysreg-
ulated, e.g., during apoptosis. For example, one of the major
water-soluble antioxidants, vitamin C (ascorbate), is routinely
used for induction of oxidative stress in conjunction with free
transition metals (such as Cu or Fe) or with hemoproteins
(such as hemoglobin, cytochrome c) [44]. Indeed, cytochrome
c2 is approximately 20 times more e¡ective at catalyzing
hydroxyl radical production from H2O2 than is free iron [64].
A series of papers have recently described the molecular
nature of the apoptosome, the multimeric molecular complex
of Apaf-1/cytochrome c/procaspase 9 [65^67]. Cytochrome c
appears necessary for the initial binding to Apaf-1, which in
the presence of ATP/dATP assembles into a multimeric com-
plex. Once this multimeric complex is formed, the recruitment
and cleavage of caspase 3 appear independent of cytochrome
c or ATP hydrolysis, however, some cytochrome c can still be
found associated with the apoptosome and could serve to
further stabilize this structure. The a⁄nity of Apaf-1 for cy-
tochrome c is extremely high (W1011 M31) [68] implying that
Fig. 2. Cytochrome c-induced oxidation of PS and PC in intact liv-
ing HL-60 cells (A) and liposomes (B). PnA was incorporated into
HL-60 cell phospholipids as previously described [27] and then incu-
bated in the presence of cytochrome c for 20 min at 37‡C (A). At
the end of this time, total lipids were extracted by the Folch proce-
dure and resolved by HPLC [27], and analyzed for £uorescent
content of PnA. Cytochrome c was incorporated into PnA-labeled
cells by mild sonication. The amount of incorporated cytochrome c
was determined spectrophotometrically and estimated as 0.44 þ
0.03 nmol/mg protein. PS, phosphatidylserine; PC, phosphatidylcho-
line. Data are means þ S.E.M., n = 14, **P6 0.04. Multilamellar dis-
persions of 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine
(PC) or 1-palmitoyl-2-arachidonyl-sn-glycero-3-phospho-L-serine (PS)
(2 mg/ml) in 50 mM phosphate bu¡er pH 7.4 were incubated in the
presence of cytochrome c (5 WM), ascorbate (500 WM), H2O2
(400 WM), desferroxamine (100 WM) during 1 h at 37‡C (B). At the
end of incubation, phospholipids were extracted and HP-TLC was
performed [27]. Oxidized phospholipid products could be resolved
as a distinct ‘tailing’ following the native unoxidized lipid spot. The
percent of oxidation was estimated by determining the phosphorus
content of the tail relative to the total lipid phosphorus available.
Data are means þ S.E.M., n = 3, *P6 0.02.
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only a few molecules of cytochrome c per cell are necessary
for apoptotic execution, especially in light of the amplifying
function of the apoptosome. Yet, cytochrome c is fairly abun-
dant and presumably released into the cytosol in excess of
that needed for Apaf^caspase interaction. In addition, it
may not be required for apoptosome function once formed.
Therefore, cytochrome c is potentially available for interac-
tions with other molecular targets. It should be kept in mind
that cytochrome c is a basic protein (pI 10.3) [69]. As a result
of this, it would more readily interact with negatively charged
molecules. Outside of mitochondria, PS is one of the two
(along with PI) negatively charged phospholipids. Physiolog-
ical localization of PS to the inner lea£et of plasma mem-
branes renders it particularly suitable for interaction with cat-
ionic cytochrome c in the cytosol. In fact, apocytochrome
c/PS interactions have been implicated in the mitochondrial
import of cytochrome c [70,71]. Moreover, apocytochrome c
has been shown to have a very high a⁄nity for PS-containing
vesicles (dissociation constant Kd less than 1 WM) [72,73]. The
initial electrostatic interaction of apocytochrome c with PS is
followed by penetration of the protein in between the acyl
chains [74]. 31P nuclear magnetic resonance studies demon-
strated that conformational changes occur in the protein on
binding to PS [75]. Numerous studies [76^78] demonstrated
the potential of cytochrome c to catalyze peroxidation of dif-
ferent phospholipids in both liposomes and membranes frag-
ments. Combined, these data suggest that cytosolic cyto-
chrome c may be involved in speci¢c interaction with PS
located in the cytosolic lea£et of plasma membrane and be
responsible for selective PS oxidation during apoptosis. In
fact, incorporation of cytochrome c into PnA-labeled HL-60
cells by gentle sonication resulted in preferential oxidation of
PS as compared to other phospholipids [32]. Furthermore, in
cell-free model systems, PS proved to be selectively oxidized
by a cytochrome c/ascorbate/H2O2 catalytic system as com-
pared to PC [32]. Fig. 2 shows that PS is preferentially oxi-
dized relative to PC when intact HL-60 cells were loaded with
cytochrome c (Fig. 2A) and when multilamellar dispersions of
PS or PC were incubated with cytochrome c/ascorbate/H2O2
(Fig. 2B).
8. Concluding remarks
Since APT inhibition is a prerequisite for PS externalization
during apoptosis, it is important to understand the mecha-
nisms by which the inhibition occurs. We speculate that PS
Scheme 1. Proposed mechanism for oxidative signaling of PS externalization during apoptosis. The left side of the scheme illustrates the com-
mon pathways of apoptotic program via mitochondrial permeability transition, cytochrome c release, apoptosome formation and caspase acti-
vation. This leads to a number of apoptotic endpoints including nuclear fragmentation and PS externalization. The right side details our pro-
posed model by which redox-active and positively charged cytochrome c interacts with negatively charged PS on the cytosolic side of the
plasma membrane. Cytochrome c catalyzed reactive oxygen species attack PS to form its hydroperoxide. Oxidatively modi¢ed PS then under-
goes spontaneous and/or scramblase-assisted externalization. The surveillance function of APT then is disrupted either by direct inhibition of
enzyme activity by reactive electrophilic PS oxidation products or failure to recognize the oxidatively modi¢ed PS. Recognition and phagocyto-
sis of apoptotic cells is then facilitated by interaction of PS with the macrophage scavenger receptor, which may preferentially bind oxidized
PS.
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oxidation acts as a su⁄cient (if not necessary) component of
apoptotic machinery ultimately contributing to PS external-
ization. Our proposed model for the lipid oxidation signaling
pathway in apoptosis is shown on Scheme 1. A variety of
apoptotic stimuli cause mitochondrial permeability transition
and release of cytochrome c from mitochondria into cytosol.
While a fraction of cytochrome c is transiently involved in
interactions with Apaf-1 within the apoptosomal complex to
initiate the caspase cascade, non-bound cytochrome c or that
released from the apoptosome is free to interact with other
membrane and cytosolic targets. Among those, the electro-
static interaction of cationic cytochrome c with anionic phos-
pholipids, such as PS, would be predicted. The extreme jux-
taposition of PS fatty acid residues with a redox-active heme-
site would favor selective oxidation of PS as opposed to other
phospholipids. Oxidized PS can then be externalized sponta-
neously and/or enzymatically (via scramblase-assisted mecha-
nism). Oxidized PS on the cell surface may be recognized as a
signal by macrophage scavenger receptor and serve to direct
phagocytosis of apoptotic cells. This may only happen if oxi-
dized PS, in contrast to non-oxidized PS, is not recognized by
APT. Alternatively, oxidized PS could be utilized by APT as a
substrate but the electrophilicity and high reactivity of the
hydroperoxy group on oxidized PS make it a potential suici-
dal substrate resulting in enzyme inactivation. Thus, cyto-
chrome c-catalyzed oxidation of PS may represent an impor-
tant component of the ¢nal common pathway associated with
signaling and recognition of apoptotic cells and their safe
elimination by professional phagocytes.
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